HAMPS
HAMPS BIO financials
- Market cap
- ₹23 Cr
Quarterly results
Q4 FY26: revenue up 34.5%, net profit down 334.8% against the same quarter last year.
| Line item | Q4 FY24 | Q2 FY25 | Q4 FY25 | Q2 FY26 | Q4 FY26 |
|---|---|---|---|---|---|
| Revenue | 3 | 4 | 3 | 4 | 4 +35% |
| EBITDA | 1 | 1 | 0 | 0 | -0 −125% |
| Net profit | 0 | 0 | 0 | -0 | -1 −335% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Performance −57.5% 1Y
1Y: ₹60 on 5 Sept 2025 → ₹25.5. High ₹60 (5 Sept 2025), low ₹15 (24 Mar 2026).
Balance sheet
| Year ending | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Equity capital | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹9 Cr | ₹9 Cr |
| Reserves | ₹-0 Cr | ₹-0 Cr | ₹1 Cr | ₹-0 Cr | ₹-1 Cr |
| Borrowings | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹4 Cr | ₹7 Cr |
| Other liabilities | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
| Total liabilities | ₹4 Cr | ₹4 Cr | ₹5 Cr | ₹13 Cr | ₹16 Cr |
| Fixed assets | ₹2 Cr | ₹3 Cr | ₹3 Cr | ₹4 Cr | ₹9 Cr |
| Capital work in progress | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹3 Cr | ₹1 Cr |
| Investments | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Other assets | ₹1 Cr | ₹1 Cr | ₹3 Cr | ₹6 Cr | ₹6 Cr |
| Total assets | ₹4 Cr | ₹4 Cr | ₹5 Cr | ₹13 Cr | ₹16 Cr |
How to read this
As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
Who owns it
As disclosed at Mar 2026
The ownership split has held steady since Mar 2025. The shareholder count shrank 4% to 395.
- Promoters
- 72.0%
- Public
- 28.0%
Since Mar 2025
- Promoters 0.00 pp
- FIIs 0.00 pp
- DIIs 0.00 pp
How it drifted, 4 quarters
Ownership split by quarter, oldest first. Dec '24: Promoters 72.0%, FIIs 0.2%, DIIs 0.1%, Public 27.8%.Mar '25: Promoters 72.0%, Public 28.0%.Sep '25: Promoters 72.0%, Public 28.0%.Mar '26: Promoters 72.0%, Public 28.0%.
Who is on the register
Named in the Mar 2026 filing
Every holder of HAMPS BIO LIMITED above SEBI's 1% disclosure line, and what changed since Sep 2025.
| Holder | Stake | Change |
|---|---|---|
| Herrik Mountbaton Shah | 31.12% | unchanged |
| Shrenik Mountkumar Shah | 23.56% | unchanged |
| Herrik Mountbaton Shah Huf | 5.27% | unchanged |
| Mountbaton S Shah Huf | 3.42% | unchanged |
| Pallavi Herrik Shah | 3.38% | unchanged |
| Shrenik Mountkumar Shah Huf | 2.94% | unchanged |
| Narayanan Ottappath | 2.30% | unchanged |
| Anil Gurmukh Bhagwani . | 1.56% | unchanged |
| Bhavya Herrik Shah | 1.47% | unchanged |
| Mitali Shrenikkumar Shah | 0.73% | unchanged |
| Alkaben Mountbaton Shah | 0.10% | unchanged |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
Learn to analyse HAMPS BIO LIMITED
Guides on how to read this kind of business and the numbers that matter.